RESEARCHER PROFILE
Hany Akeel Al-Hussaniy
← Back to University of Baghdad
H
University of Baghdad
Hany Akeel Al-Hussaniy works in Computational Drug Discovery Methods, Smoking Behavior and Cessation, COVID-19 Clinical Research Studies, Substance Abuse Treatment and Outcomes, Ethics and bioethics in healthcare. Recorded institutional associations include University of Baghdad, Al-Nisour University, Iraqi Medical Research Center.
352Publications
1,570Citations
22H-index
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Review of multiple sclerosis: Epidemiology, etiology, pathophysiology, and treatment
2024 · 287 citationsNeutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality
2022 · 189 citationsLeptin hormone and its effectiveness in reproduction, metabolism, immunity, diabetes, hopes and ambitions
2021 · 104 citationsCombination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats
2022 · 50 citationsAntimicrobial management of dental infections: Updated review
2024 · 48 citationsChemotherapy-induced cardiotoxicity: a new perspective on the role of Digoxin, ATG7 activators, Resveratrol, and herbal drugs
2023 · 44 citationsDoxorubicin-Induced Cardiotoxicity: Molecular Mechanism and Protection by Conventional Drugs and Natural Products
2017 · 43 citationsThe Use of PCR for Respiratory Virus Detection on the Diagnosis and Treatment Decision of Respiratory Tract Infections in Iraq
2022 · 39 citationsPanax ginseng as Antioxidant and Anti-inflammatory to reduce the Cardiotoxicity of Doxorubicin on rat module
2022 · 36 citationsThe Effect of MicroRNA-409-3p for Treatment and Response to Tumor Proliferation of Lung Cancer Cell Lines (In Vitro)
2022 · 36 citationsAntiepileptic Effect of Neuroaid® on Strychnine-Induced Convulsions in Mice
2022 · 35 citationsNon-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes
2023 · 33 citationsPHARMACOLOGICAL PROPERTIES OF SPIRULINA SPECIES: HEPATOPROTECTIVE, ANTIOXIDANT AND ANTICANCER EFFECTS
2023 · 32 citationsClinical Pharmacogenetics of Angiotensin II Receptor Blockers in Iraq
2023 · 31 citationsThe Effect of Nefopam Hydrochloride on the Liver, Heart, and Brain of Rats: Acute Toxicity and Mechanisms of Nefopam Toxicity
2022 · 30 citationsThe relationship between statin therapy and adipocytokine/inflammatory mediators in dyslipidemic nondiabetic patients: A comparative study
2023 · 29 citationsEffects of Mdm2 Inhibitors on Cellular Viability of Breast Cancer Cell Lines HP100, MCF7
2024 · 28 citationsIncreasing Prevalence of Congenital Hypothyroidism in children with Down Syndrome who have a family history of Thyroid disease
2023 · 28 citationsThe role of COVID-19 in myopathy: incidence, causes, treatment, and prevention
2022 · 28 citationsNanoemulsions as medicinal components in insoluble medicines
2023 · 27 citationsIn silico identification of antiviral compounds for the treatment of chikungunya virus infection: qsar modelling and md simulation analysis
2024 · 24 citationsFEBUXOSTAT MODULATES OXIDATIVE AND APOPTOTIC PATHWAYS IN ACUTE DOXORUBICIN‑INDUCED CARDIOTOXICITY: AN EXPERIMENTAL ANIMAL MODEL STUDY
2019 · 22 citationsEndoscopic characteristics and management of Subepithelial Lesions in Video-Gastascopie
2022 · 21 citationsThe Role of Leptin Hormone, Neuropeptide Y, Ghrelin and Leptin/Ghrelin ratio in Obesogenesis
2022 · 21 citationsCytotoxic Effect of YH239-EE and Its Enantiomer on MCF7 Cell Line
2024 · 20 citations
